We are live on ! Find out more
BLPH

Bellerophon Therapeutics, Inc.

Delisted

BLPH was delisted on the 13th of October, 2023.

Name Holding Trade Value Shares
Change
Change in
Stake
NMVA
1
New Mountain Vantage Advisers
New York
$14.4M
PCM
2
Puissance Capital Management
New York
$5.42M
VMI
3
VHCP Management II
New York
$2.71M
AC
4
Armistice Capital
New York
$1.89M +$2.13M +193,333 New
VMI
5
VHCP Management III
New York
$1.58M +$105K +9,523 +6%
Renaissance Technologies
6
Renaissance Technologies
New York
$860K +$45.7K +4,147 +5%
Vanguard Group
7
Vanguard Group
Pennsylvania
$649K +$195K +17,696 +36%
AVM
8
Arch Venture Management
Illinois
$631K
SM
9
Sabby Management
Florida
$202K +$227K +20,594 New
Geode Capital Management
10
Geode Capital Management
Massachusetts
$152K
TI
11
Telemetry Investments
New York
$126K +$142K +12,897 New
Bank of New York Mellon
12
Bank of New York Mellon
New York
$114K -$22 -2 -0%
BCM
13
Bridgeway Capital Management
Texas
$103K -$18.4K -1,667 -14%
LPL Financial
14
LPL Financial
California
$70K +$10.8K +980 +16%
Northern Trust
15
Northern Trust
Illinois
$50K +$10.8K +981 +24%
BlackRock
16
BlackRock
New York
$40K -$3.1K -281 -6%
Citadel Advisors
17
Citadel Advisors
Florida
$35K +$39.9K +3,621 New
Millennium Management
18
Millennium Management
New York
$22K -$2.52K -229 -9%
TSS
19
Two Sigma Securities
New York
$15K +$17K +1,540 New
UBS Group
20
UBS Group
Switzerland
$13K +$209 +19 +1%
US Bancorp
21
US Bancorp
Minnesota
$12K
VF
22
Virtu Financial
New York
$11K -$14.9K -1,348 -55%
State Street
23
State Street
Massachusetts
$9K
GCM
24
Gables Capital Management
Florida
$1K
FDCDDQ
25
Federation des caisses Desjardins du Quebec
Quebec, Canada
$653